{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:12:40Z","timestamp":1769587960821,"version":"3.49.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,25]]},"DOI":"10.7759\/cureus.74452","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T05:01:43Z","timestamp":1732597303000},"source":"Crossref","is-referenced-by-count":1,"title":["Current Advances in Lipid-Based Drug Delivery Systems as Nanocarriers for the Management of Female Genital Tuberculosis"],"prefix":"10.7759","author":[{"given":"Dhanashri D","family":"Chavan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit R","family":"Bhosale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vandana M","family":"Thorat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay R","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachinkumar V","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagyesh U","family":"Janugade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarika J","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijtb.2017.01.006","article-title":"Concomitant female genital tuberculosis and endometriosis","volume":"64","author":"Sharma JB","year":"2017","unstructured":"Sharma JB, Goyal M, Kumar S, Roy KK, Sharma E, Arora R. Concomitant female genital tuberculosis and endometriosis. Indian J Tuberc. 2017, 64:173-7. 10.1016\/j.ijtb.2017.01.006","journal-title":"Indian J Tuberc"},{"key":"ref2","article-title":"Hypertrophic tuberculosis of vulva--a rare presentation of tuberculosis","volume":"57","author":"Tiwari P","year":"2010","unstructured":"Tiwari P, Pal DK, Moulik D, Choudhury MK. Hypertrophic tuberculosis of vulva--a rare presentation of tuberculosis. Indian J Tuberc. 2010, 57:95-7.","journal-title":"Indian J Tuberc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_648_18","article-title":"Female genital tuberculosis: revisited","volume":"148","author":"Sharma JB","year":"2018","unstructured":"Sharma JB, Sharma E, Sharma S, Dharmendra S. Female genital tuberculosis: revisited. Indian J Med Res. 2018, 148:S71-83. 10.4103\/ijmr.IJMR_648_18","journal-title":"Indian J Med Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.192050","article-title":"Effect of antitubercular treatment on ovarian function in female genital tuberculosis with infertility","volume":"9","author":"Sharma JB","year":"2016","unstructured":"Sharma JB, Sneha J, Singh UB, Kumar S, Roy KK, Singh N, Dharmendra S. Effect of antitubercular treatment on ovarian function in female genital tuberculosis with infertility. J Hum Reprod Sci. 2016, 9:145-50. 10.4103\/0974-1208.192050","journal-title":"J Hum Reprod Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2298\/vsp0712855p","article-title":"Female genital tuberculosis--a disease seen again in Europe","volume":"64","author":"Pesut D","year":"2007","unstructured":"Pesut D, Stojsi\u0107 J. Female genital tuberculosis--a disease seen again in Europe. Vojnosanit Pregl. 2007, 64:855-8. 10.2298\/vsp0712855p","journal-title":"Vojnosanit Pregl"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1550_15","article-title":"Genital tuberculosis in females","volume":"145","author":"Grace GA","year":"2017","unstructured":"Grace GA, Devaleenal DB, Natrajan M. Genital tuberculosis in females. Indian J Med Res. 2017, 145:425-36. 10.4103\/ijmr.IJMR_1550_15","journal-title":"Indian J Med Res"},{"key":"ref7","article-title":"Extrapulmonary tuberculosis: an overview","volume":"72","author":"Golden MP","year":"2005","unstructured":"Golden MP, Vikram HR. Extrapulmonary tuberculosis: an overview. Am Fam Physician. 2005, 72:1761-8.","journal-title":"Am Fam Physician"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211014999","article-title":"Emerging progress on diagnosis and treatment of female genital tuberculosis","volume":"49","author":"Wang Y","year":"2021","unstructured":"Wang Y, Shao R, He C, Chen L. Emerging progress on diagnosis and treatment of female genital tuberculosis. J Int Med Res. 2021, 49:10.1177\/03000605211014999","journal-title":"J Int Med Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2011.568523","article-title":"Female genital tuberculosis: a review","volume":"43","author":"Neonakis IK","year":"2011","unstructured":"Neonakis IK, Spandidos DA, Petinaki E. Female genital tuberculosis: a review. Scand J Infect Dis. 2011, 43:564-72. 10.3109\/00365548.2011.568523","journal-title":"Scand J Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2727.180794","article-title":"Sharma\u2019s python sign: a new tubal sign in female genital tuberculosis","volume":"8","author":"Sharma JB","year":"2016","unstructured":"Sharma JB. Sharma\u2019s python sign: a new tubal sign in female genital tuberculosis. J Lab Physicians. 2016, 8:120-2. 10.4103\/0974-2727.180794","journal-title":"J Lab Physicians"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-015-0780-z","article-title":"Current diagnosis and management of female genital tuberculosis","volume":"65","author":"Sharma JB","year":"2015","unstructured":"Sharma JB. Current diagnosis and management of female genital tuberculosis. J Obstet Gynaecol India. 2015, 65:362-71. 10.1007\/s13224-015-0780-z","journal-title":"J Obstet Gynaecol India"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00003081-197603000-00016","article-title":"Female genital tuberculosis","volume":"19","author":"Schaefer G","year":"1976","unstructured":"Schaefer G. Female genital tuberculosis. Clin Obstet Gynecol. 1976, 19:223-39. 10.1097\/00003081-197603000-00016","journal-title":"Clin Obstet Gynecol"},{"key":"ref13","article-title":"Genital tuberculosis in women. Analysis of 187 newly diagnosed cases from 47 Swedish hospitals during the ten-year period 1968 to 1977","volume":"138","author":"Falk V","year":"1980","unstructured":"Falk V, Ludviksson K, Agren G. Genital tuberculosis in women. Analysis of 187 newly diagnosed cases from 47 Swedish hospitals during the ten-year period 1968 to 1977. Am J Obstet Gynecol. 1980, 138:974-7.","journal-title":"Am J Obstet Gynecol"},{"key":"ref14","article-title":"Incidence of genital tuberculosis in infertile women","volume":"35","author":"Khan SM","year":"1985","unstructured":"Khan SM. Incidence of genital tuberculosis in infertile women. J Pak Med Assoc. 1985, 35:280-1.","journal-title":"J Pak Med Assoc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0022-3859.90082","article-title":"Tuberculosis and female reproductive health","volume":"57","author":"Ghosh K","year":"2011","unstructured":"Ghosh K, Ghosh K, Chowdhury JR. Tuberculosis and female reproductive health. J Postgrad Med. 2011, 57:307-13. 10.4103\/0022-3859.90082","journal-title":"J Postgrad Med"},{"key":"ref16","article-title":"Genital tuberculosis at Tygerberg Hospital--prevalence, clinical presentation and diagnosis","volume":"81","author":"Margolis K","year":"1992","unstructured":"Margolis K, Wranz PA, Kruger TF, Joubert JJ, Odendaal HJ. Genital tuberculosis at Tygerberg Hospital--prevalence, clinical presentation and diagnosis. S Afr Med J. 1992, 81:12-5.","journal-title":"S Afr Med J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0020-7292(01)00525-2","article-title":"Infertility and pregnancy outcome in female genital tuberculosis","volume":"76","author":"Tripathy SN","year":"2002","unstructured":"Tripathy SN, Tripathy SN. Infertility and pregnancy outcome in female genital tuberculosis. Int J Gynaecol Obstet. 2002, 76:159-63. 10.1016\/s0020-7292(01)00525-2","journal-title":"Int J Gynaecol Obstet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1983.tb06752.x","article-title":"Tuberculous endometritis: a clinicopathological study of 1000 cases","volume":"90","author":"Bazaz-Malik G","year":"1983","unstructured":"Bazaz-Malik G, Maheshwari B, Lal N. Tuberculous endometritis: a clinicopathological study of 1000 cases. Br J Obstet Gynaecol. 1983, 90:84-6. 10.1111\/j.1471-0528.1983.tb06752.x","journal-title":"Br J Obstet Gynaecol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2006.12.018","article-title":"Genital tuberculosis in Indian infertility patients","volume":"97","author":"Gupta N","year":"2007","unstructured":"Gupta N, Sharma JB, Mittal S, Singh N, Misra R, Kukreja M. Genital tuberculosis in Indian infertility patients. Int J Gynaecol Obstet. 2007, 97:135-8. 10.1016\/j.ijgo.2006.12.018","journal-title":"Int J Gynaecol Obstet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-008-0590-y","article-title":"Genital tuberculosis: a leading cause for infertility in women seeking assisted conception in North India","volume":"278","author":"Singh N","year":"2008","unstructured":"Singh N, Sumana G, Mittal S. Genital tuberculosis: a leading cause for infertility in women seeking assisted conception in North India. Arch Gynecol Obstet. 2008, 278:325-7. 10.1007\/s00404-008-0590-y","journal-title":"Arch Gynecol Obstet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/0255-0857.55461","article-title":"Female genital TB and HIV co-infection","volume":"27","author":"Duggal S","year":"2009","unstructured":"Duggal S, Duggal N, Hans C, Mahajan RK. Female genital TB and HIV co-infection. Indian J Med Microbiol. 2009, 27:361-3. 10.4103\/0255-0857.55461","journal-title":"Indian J Med Microbiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2012.04.005","article-title":"Clinical presentation and epidemiology of female genital tuberculosis in eastern Sudan","volume":"118","author":"Ali AA","year":"2012","unstructured":"Ali AA, Abdallah TM. Clinical presentation and epidemiology of female genital tuberculosis in eastern Sudan. Int J Gynaecol Obstet. 2012, 118:236-8. 10.1016\/j.ijgo.2012.04.005","journal-title":"Int J Gynaecol Obstet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098005","article-title":"Use of endo-ovarian tissue biopsy and pelvic aspirated fluid for the diagnosis of female genital tuberculosis by conventional versus molecular methods","volume":"9","author":"Bhanothu V","year":"2014","unstructured":"Bhanothu V, Theophilus JP, Rozati R. Use of endo-ovarian tissue biopsy and pelvic aspirated fluid for the diagnosis of female genital tuberculosis by conventional versus molecular methods. PLoS One. 2014, 9:e98005. 10.1371\/journal.pone.0098005","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.52783\/jchr.v13.i6.1715","article-title":"Prevalence of tuberculosis and associated clinical features among the population of central part of Bihar","volume":"13","author":"Kumar C","year":"2023","unstructured":"Kumar C, Kumar N. Prevalence of tuberculosis and associated clinical features among the population of central part of Bihar. J Chem Health Risks. 2023, 13:10.52783\/jchr.v13.i6.1715","journal-title":"J Chem Health Risks"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/745060","article-title":"Genital tuberculosis as the cause of tuboovarian abscess in an immunosuppressed patient","volume":"2009","author":"Ilmer M","year":"2009","unstructured":"Ilmer M, Bergauer F, Friese K, Mylonas I. Genital tuberculosis as the cause of tuboovarian abscess in an immunosuppressed patient. Infect Dis Obstet Gynecol. 2009, 2009:745060. 10.1155\/2009\/745060","journal-title":"Infect Dis Obstet Gynecol"},{"key":"ref26","article-title":"Female genital tract tuberculosis: how long will it elude diagnosis?","volume":"134","author":"Bose M","year":"2011","unstructured":"Bose M. Female genital tract tuberculosis: how long will it elude diagnosis?. Indian J Med Res. 2011, 134:13-4.","journal-title":"Indian J Med Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h6747","article-title":"Tuberculosis--diagnosis, management, prevention, and control: summary of updated NICE guidance","volume":"352","author":"Hoppe LE","year":"2016","unstructured":"Hoppe LE, Kettle R, Eisenhut M, Abubakar I. Tuberculosis--diagnosis, management, prevention, and control: summary of updated NICE guidance. BMJ. 2016, 352:h6747. 10.1136\/bmj.h6747","journal-title":"BMJ"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.130817","article-title":"Genital tuberculosis: comparative study of the diagnostic modalities","volume":"7","author":"Shrivastava G","year":"2014","unstructured":"Shrivastava G, Bajpai T, Bhatambare GS, Patel KB. Genital tuberculosis: comparative study of the diagnostic modalities. J Hum Reprod Sci. 2014, 7:30-3. 10.4103\/0974-1208.130817","journal-title":"J Hum Reprod Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4103\/GMIT.GMIT_25_20","article-title":"Female genital tuberculosis: five case reports","volume":"10","author":"Kaya A","year":"2021","unstructured":"Kaya A, Kaya SY, Zerdali E, Can A. Female genital tuberculosis: five case reports. Gynecol Minim Invasive Ther. 2021, 10:41-3. 10.4103\/GMIT.GMIT_25_20","journal-title":"Gynecol Minim Invasive Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120321","article-title":"Lipid nanoparticles with improved biopharmaceutical attributes for tuberculosis treatment","volume":"596","author":"Gordillo-Galeano A","year":"2021","unstructured":"Gordillo-Galeano A, Ospina-Giraldo LF, Mora-Huertas CE. Lipid nanoparticles with improved biopharmaceutical attributes for tuberculosis treatment. Int J Pharm. 2021, 596:120321. 10.1016\/j.ijpharm.2021.120321","journal-title":"Int J Pharm"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2023.100190","article-title":"Genetic variants associated with spontaneous preterm birth in women from India: a prospective cohort study","volume":"14","author":"Bhattacharjee E","year":"2023","unstructured":"Bhattacharjee E, Thiruvengadam R, Ayushi, et al.. Genetic variants associated with spontaneous preterm birth in women from India: a prospective cohort study. Lancet Reg Health Southeast Asia. 2023, 14:100190. 10.1016\/j.lansea.2023.100190","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-018-0615-2","article-title":"Effect of antitubercular treatment on the pregnancy outcomes and prognoses of patients with genital tuberculosis","volume":"13","author":"Yue J","year":"2019","unstructured":"Yue J, Zhang B, Wang M, Yao J, Zhou Y, Ma D, Jin L. Effect of antitubercular treatment on the pregnancy outcomes and prognoses of patients with genital tuberculosis. Front Med. 2019, 13:121-5. 10.1007\/s11684-018-0615-2","journal-title":"Front Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2009.08.031","article-title":"Second-look hysteroscopy after antitubercular treatment in infertile women with genital tuberculosis undergoing in vitro fertilization","volume":"108","author":"Bahadur A","year":"2010","unstructured":"Bahadur A, Malhotra N, Mittal S, Singh N, Gurunath S. Second-look hysteroscopy after antitubercular treatment in infertile women with genital tuberculosis undergoing in vitro fertilization. Int J Gynaecol Obstet. 2010, 108:128-31. 10.1016\/j.ijgo.2009.08.031","journal-title":"Int J Gynaecol Obstet"},{"key":"ref34","article-title":"Investigation of the prevalence of female genital tract tuberculosis and its relation to female infertility: an observational analytical study","volume":"10","author":"Shahzad S","year":"2012","unstructured":"Shahzad S. Investigation of the prevalence of female genital tract tuberculosis and its relation to female infertility: an observational analytical study. Iran J Reprod Med. 2012, 10:581-8.","journal-title":"Iran J Reprod Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des076","article-title":"Favorable infertility outcomes following anti-tubercular treatment prescribed on the sole basis of a positive polymerase chain reaction test for endometrial tuberculosis","volume":"27","author":"Jindal UN","year":"2012","unstructured":"Jindal UN, Verma S, Bala Y. Favorable infertility outcomes following anti-tubercular treatment prescribed on the sole basis of a positive polymerase chain reaction test for endometrial tuberculosis. Hum Reprod. 2012, 27:1368-74. 10.1093\/humrep\/des076","journal-title":"Hum Reprod"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0800106","article-title":"Comprehensive treatment of extensively drug-resistant tuberculosis","volume":"359","author":"Mitnick CD","year":"2008","unstructured":"Mitnick CD, Shin SS, Seung KJ, et al.. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 2008, 359:563-74. 10.1056\/NEJMoa0800106","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac543","article-title":"Female genital tuberculosis","volume":"9","author":"Tzelios C","year":"2022","unstructured":"Tzelios C, Neuhausser WM, Ryley D, Vo N, Hurtado RM, Nathavitharana RR. Female genital tuberculosis. Open Forum Infect Dis. 2022, 9:ofac543. 10.1093\/ofid\/ofac543","journal-title":"Open Forum Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.5b00046","article-title":"New developments in liposomal drug delivery","volume":"115","author":"Pattni BS","year":"2015","unstructured":"Pattni BS, Chupin VV, Torchilin VP. New developments in liposomal drug delivery. Chem Rev. 2015, 115:10938-66. 10.1021\/acs.chemrev.5b00046","journal-title":"Chem Rev"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1039\/b600913c","article-title":"Imparting size, shape, and composition control of materials for nanomedicine","volume":"35","author":"Euliss LE","year":"2006","unstructured":"Euliss LE, DuPont JA, Gratton S, DeSimone J. Imparting size, shape, and composition control of materials for nanomedicine. Chem Soc Rev. 2006, 35:1095-104. 10.1039\/b600913c","journal-title":"Chem Soc Rev"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.05.192","article-title":"A systematic study on chitosan-liposome based systems for biomedical applications","volume":"160","author":"Kumar S","year":"2020","unstructured":"Kumar S, Dutta J, Dutta PK, Koh J. A systematic study on chitosan-liposome based systems for biomedical applications. Int J Biol Macromol. 2020, 160:470-81. 10.1016\/j.ijbiomac.2020.05.192","journal-title":"Int J Biol Macromol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.84255","article-title":"General perception of liposomes: formation, manufacturing and applications","author":"Nkanga CI","year":"2019","unstructured":"Nkanga CI, Bapolisi AM, Okafor NI, Krause RWM. General perception of liposomes: formation, manufacturing and applications. Liposomes - Advances and Perspectives. Catala A (ed): IntechOpen, London, UK; 2019. 10.5772\/intechopen.84255"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.9b00539","article-title":"Functionalization of liposomes with hydrophilic polymers results in macrophage uptake independent of the protein corona","volume":"20","author":"Weber C","year":"2019","unstructured":"Weber C, Voigt M, Simon J, et al.. Functionalization of liposomes with hydrophilic polymers results in macrophage uptake independent of the protein corona. Biomacromolecules. 2019, 20:2989-99. 10.1021\/acs.biomac.9b00539","journal-title":"Biomacromolecules"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.05.038","article-title":"Respirable nanocarriers as a promising strategy for antitubercular drug delivery","volume":"187","author":"Mehanna MM","year":"2014","unstructured":"Mehanna MM, Mohyeldin SM, Elgindy NA. Respirable nanocarriers as a promising strategy for antitubercular drug delivery. J Control Release. 2014, 187:183-97. 10.1016\/j.jconrel.2014.05.038","journal-title":"J Control Release"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.b.31608","article-title":"In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis","volume":"94","author":"Chimote G","year":"2010","unstructured":"Chimote G, Banerjee R. In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis. J Biomed Mater Res B Appl Biomater. 2010, 94:1-10. 10.1002\/jbm.b.31608","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake U","year":"2017","unstructured":"Bulbake U, Doppalapudi S, Kommineni N, Khan W. Liposomal formulations in clinical use: an updated review. Pharmaceutics. 2017, 9:12. 10.3390\/pharmaceutics9020012","journal-title":"Pharmaceutics"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b16-00624","article-title":"Liposomal delivery systems: design optimization and current applications","volume":"40","author":"Abu Lila AS","year":"2017","unstructured":"Abu Lila AS, Ishida T. Liposomal delivery systems: design optimization and current applications. Biol Pharm Bull. 2017, 40:1-10. 10.1248\/bpb.b16-00624","journal-title":"Biol Pharm Bull"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2020.106127","article-title":"Nano-based drug delivery optimization for tuberculosis treatment: a review","volume":"181","author":"Dahanayake MH","year":"2021","unstructured":"Dahanayake MH, Jayasundera AC. Nano-based drug delivery optimization for tuberculosis treatment: a review. J Microbiol Methods. 2021, 181:106127. 10.1016\/j.mimet.2020.106127","journal-title":"J Microbiol Methods"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.4103\/0970-2113.159559","article-title":"A novel approach for lung delivery of rifampicin-loaded liposomes in dry powder form for the treatment of tuberculosis","volume":"32","author":"Patil JS","year":"2015","unstructured":"Patil JS, Devi VK, Devi K, Sarasija S. A novel approach for lung delivery of rifampicin-loaded liposomes in dry powder form for the treatment of tuberculosis. Lung India. 2015, 32:331-8. 10.4103\/0970-2113.159559","journal-title":"Lung India"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/s0163-7827(00)00011-4","article-title":"Current status of pH-sensitive liposomes in drug delivery","volume":"39","author":"Drummond DC","year":"2000","unstructured":"Drummond DC, Zignani M, Leroux JC. Current status of pH-sensitive liposomes in drug delivery. Prog Lipid Res. 2000, 39:409-60. 10.1016\/s0163-7827(00)00011-4","journal-title":"Prog Lipid Res"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.59.4.0001","article-title":"pH-sensitive liposomes--principle and application in cancer therapy","volume":"59","author":"Karanth H","year":"2007","unstructured":"Karanth H, Murthy RS. pH-sensitive liposomes--principle and application in cancer therapy. J Pharm Pharmacol. 2007, 59:469-83. 10.1211\/jpp.59.4.0001","journal-title":"J Pharm Pharmacol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1590\/S0104-66322012000200013","article-title":"Characterization of lyophilized liposomes produced with non-purified soy lecithin: a case study of casein hydrolysate microencapsulation","volume":"29","author":"Yokota D","year":"2012","unstructured":"Yokota D, Moraes M, Pinho SC. Characterization of lyophilized liposomes produced with non-purified soy lecithin: a case study of casein hydrolysate microencapsulation. Brazilian J Chem Eng. 2012, 29:325-35. 10.1590\/S0104-66322012000200013","journal-title":"Brazilian J Chem Eng"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.04.074","article-title":"Preparation and characterization of isoniazid-loaded crude soybean lecithin liposomes","volume":"526","author":"Nkanga CI","year":"2017","unstructured":"Nkanga CI, Krause RW, Noundou XS, Walker RB. Preparation and characterization of isoniazid-loaded crude soybean lecithin liposomes. Int J Pharm. 2017, 526:466-73. 10.1016\/j.ijpharm.2017.04.074","journal-title":"Int J Pharm"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.08.030","article-title":"Comparison of adjuvants to optimize influenza neutralizing antibody responses","volume":"37","author":"Rudicell RS","year":"2019","unstructured":"Rudicell RS, Garinot M, Kanekiyo M, et al.. Comparison of adjuvants to optimize influenza neutralizing antibody responses. Vaccine. 2019, 37:6208-20. 10.1016\/j.vaccine.2019.08.030","journal-title":"Vaccine"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2018.03.016","article-title":"pH-dependent release of isoniazid from isonicotinic acid (4-hydroxy-benzylidene)-hydrazide loaded liposomes","volume":"45","author":"Nkanga CI","year":"2018","unstructured":"Nkanga CI, Walker RB, Krause RW. pH-dependent release of isoniazid from isonicotinic acid (4-hydroxy-benzylidene)-hydrazide loaded liposomes. J Drug Deliv Sci Technol. 2018, 45:264-71. 10.1016\/j.jddst.2018.03.016","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47991-y","article-title":"Encapsulation of isoniazid-conjugated phthalocyanine-in-cyclodextrin-in-liposomes using heating method","volume":"9","author":"Nkanga CI","year":"2019","unstructured":"Nkanga CI, Krause RW. Encapsulation of isoniazid-conjugated phthalocyanine-in-cyclodextrin-in-liposomes using heating method. Sci Rep. 2019, 9:11485. 10.1038\/s41598-019-47991-y","journal-title":"Sci Rep"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1166\/jbn.2020.2880","article-title":"Co-loading of isoniazid-grafted phthalocyanine-in-cyclodextrin and rifampicin in crude soybean lecithin liposomes: formulation, spectroscopic and biological characterization","volume":"16","author":"Nkanga CI","year":"2020","unstructured":"Nkanga CI, Roth M, Walker RB, Noundou XS, Krause RW. Co-loading of isoniazid-grafted phthalocyanine-in-cyclodextrin and rifampicin in crude soybean lecithin liposomes: formulation, spectroscopic and biological characterization. J Biomed Nanotechnol. 2020, 16:14-28. 10.1166\/jbn.2020.2880","journal-title":"J Biomed Nanotechnol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101581","article-title":"Niosomes: a review on niosomal research in the last decade","volume":"56","author":"Bhardwaj P","year":"2020","unstructured":"Bhardwaj P, Tripathi P, Gupta R, Pandey S. Niosomes: a review on niosomal research in the last decade. J Drug Deliv Sci Technol. 2020, 56:101581. 10.1016\/j.jddst.2020.101581","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.5812\/ijpr-130626","article-title":"Particle size tailoring of quercetin nanosuspensions by wet media milling technique: a study on processing and formulation parameters","volume":"21","author":"Cheshmehnoor P","year":"2022","unstructured":"Cheshmehnoor P, Bolourchian N, Abdollahizad E, Derakhshi A, Dadashzadeh S, Haeri A. Particle size tailoring of quercetin nanosuspensions by wet media milling technique: a study on processing and formulation parameters. Iran J Pharm Res. 2022, 21:e130626. 10.5812\/ijpr-130626","journal-title":"Iran J Pharm Res"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.102234","article-title":"An illustrated review on nonionic surfactant vesicles (niosomes) as an approach in modern drug delivery: fabrication, characterization, pharmaceutical, and cosmetic applications","volume":"61","author":"Masjedi M","year":"2021","unstructured":"Masjedi M, Montahaei T. An illustrated review on nonionic surfactant vesicles (niosomes) as an approach in modern drug delivery: fabrication, characterization, pharmaceutical, and cosmetic applications. J Drug Deliv Sci Technol. 2021, 61:102234. 10.1016\/j.jddst.2020.102234","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1691\/ph.2019.8168","article-title":"Development, manufacture and characterization of niosomes for the delivery for nevirapine","volume":"74","author":"Witika BA","year":"2019","unstructured":"Witika BA, Walker RB. Development, manufacture and characterization of niosomes for the delivery for nevirapine. Pharmazie. 2019, 74:91-6. 10.1691\/ph.2019.8168","journal-title":"Pharmazie"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2018.05.021","article-title":"Lipid based nanocarriers: a translational perspective","volume":"14","author":"Mishra DK","year":"2018","unstructured":"Mishra DK, Shandilya R, Mishra PK. Lipid based nanocarriers: a translational perspective. Nanomedicine. 2018, 14:2023-50. 10.1016\/j.nano.2018.05.021","journal-title":"Nanomedicine"},{"key":"ref62","article-title":"Preparation, characterization and tissue disposition of niosomes containing isoniazid","volume":"1","author":"Karki R","year":"2008","unstructured":"Karki R, Mamatha GC, Subramanya G, Udupa N. Preparation, characterization and tissue disposition of niosomes containing isoniazid. Rasayan J Chem. 2008, 1:224-7.","journal-title":"Rasayan J Chem"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3390\/nano10091649","article-title":"Biocompatibility of biomaterials for nanoencapsulation: current approaches","volume":"10","author":"Witika BA","year":"2020","unstructured":"Witika BA, Makoni PA, Matafwali SK, et al.. Biocompatibility of biomaterials for nanoencapsulation: current approaches. Nanomaterials (Basel). 2020, 10:1649. 10.3390\/nano10091649","journal-title":"Nanomaterials (Basel)"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3109\/02652049509087252","article-title":"Preparation and characterization of niosomes containing rifampicin for lung targeting","volume":"12","author":"Jain CP","year":"1995","unstructured":"Jain CP, Vyas SP. Preparation and characterization of niosomes containing rifampicin for lung targeting. J Microencapsul. 1995, 12:401-7. 10.3109\/02652049509087252","journal-title":"J Microencapsul"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.4314\/tjpr.v10i2.66564","article-title":"Niosomal delivery of isoniazid - development and characterization","volume":"10","author":"Singh G","year":"2011","unstructured":"Singh G, Dwivedi H, Saraf SK, Saraf SA. Niosomal delivery of isoniazid - development and characterization. Trop J Pharm Res. 2011, 10:203-10. 10.4314\/tjpr.v10i2.66564","journal-title":"Trop J Pharm Res"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2011.560605","article-title":"Niosomal encapsulation of the antitubercular drug, pyrazinamide","volume":"37","author":"El-Ridy MS","year":"2011","unstructured":"El-Ridy MS, Abdelbary A, Nasr EA, Khalil RM, Mostafa DM, El-Batal AI, Abd El-Alim SH. Niosomal encapsulation of the antitubercular drug, pyrazinamide. Drug Dev Ind Pharm. 2011, 37:1110-8. 10.3109\/03639045.2011.560605","journal-title":"Drug Dev Ind Pharm"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2011.05.018","article-title":"Quantitative investigation, stability and in vitro release studies of anti-TB drugs in Triton niosomes","volume":"87","author":"Mehta SK","year":"2011","unstructured":"Mehta SK, Jindal N, Kaur G. Quantitative investigation, stability and in vitro release studies of anti-TB drugs in Triton niosomes. Colloids Surf B Biointerfaces. 2011, 87:173-9. 10.1016\/j.colsurfb.2011.05.018","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2012.07.006","article-title":"Formulation of tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs","volume":"101","author":"Mehta SK","year":"2013","unstructured":"Mehta SK, Jindal N. Formulation of tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs. Colloids Surf B Biointerfaces. 2013, 101:434-41. 10.1016\/j.colsurfb.2012.07.006","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071855","article-title":"Chitosan-coated SLN: a potential system for ocular delivery of metronidazole","volume":"15","author":"Sikhondze SS","year":"2023","unstructured":"Sikhondze SS, Makoni PA, Walker RB, Khamanga SM. Chitosan-coated SLN: a potential system for ocular delivery of metronidazole. Pharmaceutics. 2023, 15:1855. 10.3390\/pharmaceutics15071855","journal-title":"Pharmaceutics"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.02.038","article-title":"Lipid-based nanosuspensions for oral delivery of peptides, a critical review","volume":"541","author":"Dumont C","year":"2018","unstructured":"Dumont C, Bourgeois S, Fessi H, Jannin V. Lipid-based nanosuspensions for oral delivery of peptides, a critical review. Int J Pharm. 2018, 541:117-35. 10.1016\/j.ijpharm.2018.02.038","journal-title":"Int J Pharm"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfoodeng.2020.110451","article-title":"Lipid-based carriers for food ingredients delivery","volume":"295","author":"Barroso L","year":"2020","unstructured":"Barroso L, Viegas C, Vieira J, Ferreira-Pego C, Costa J, Fonte P. Lipid-based carriers for food ingredients delivery. J Food Eng. 2020, 295:110451. 10.1016\/j.jfoodeng.2020.110451","journal-title":"J Food Eng"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/s0169-409x(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert W","year":"2001","unstructured":"Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001, 47:165-96. 10.1016\/s0169-409x(01)00105-3","journal-title":"Adv Drug Deliv Rev"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1368481","article-title":"Solid lipid nanoparticles improve the diclofenac availability in vitreous after intraocular injection","volume":"2016","author":"Abrishami M","year":"2016","unstructured":"Abrishami M, Abrishami M, Mahmoudi A, Mosallaei N, Vakili Ahrari Roodi M, Malaekeh-Nikouei B. Solid lipid nanoparticles improve the diclofenac availability in vitreous after intraocular injection. J Drug Deliv. 2016, 2016:1368481. 10.1155\/2016\/1368481","journal-title":"J Drug Deliv"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2016.07.062","article-title":"Solid lipid nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment- a design of experiments approach to investigate the influence of pre-freezing conditions on the powder respirability","volume":"511","author":"Maretti E","year":"2016","unstructured":"Maretti E, Rustichelli C, Romagnoli M, et al.. Solid lipid nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment- a design of experiments approach to investigate the influence of pre-freezing conditions on the powder respirability. Int J Pharm. 2016, 511:669-79. 10.1016\/j.ijpharm.2016.07.062","journal-title":"Int J Pharm"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.11.071","article-title":"Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis","volume":"536","author":"Vieira AC","year":"2018","unstructured":"Vieira AC, Chaves LL, Pinheiro S, et al.. Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis. Int J Pharm. 2018, 536:478-85. 10.1016\/j.ijpharm.2017.11.071","journal-title":"Int J Pharm"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1186\/2228-5326-2-33","article-title":"Improved antimycobacterial activity of rifampin using solid lipid nanoparticles","volume":"2","author":"Aboutaleb E","year":"2012","unstructured":"Aboutaleb E, Noori M, Gandomi N, Atyabi F, Fazeli MR, Jamalifar H, Dinarvand R. Improved antimycobacterial activity of rifampin using solid lipid nanoparticles. Int Nano Lett. 2012, 2:33. 10.1186\/2228-5326-2-33","journal-title":"Int Nano Lett"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2004.11.003","article-title":"Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis","volume":"85","author":"Pandey R","year":"2005","unstructured":"Pandey R, Khuller GK. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis (Edinb). 2005, 85:227-34. 10.1016\/j.tube.2004.11.003","journal-title":"Tuberculosis (Edinb)"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2015.09.004","article-title":"Nanostructured lipid carriers: promising drug delivery systems for future clinics","volume":"12","author":"Beloqui A","year":"2016","unstructured":"Beloqui A, Solin\u00eds M\u00c1, Rodr\u00edguez-Gasc\u00f3n A, Almeida AJ, Pr\u00e9at V. Nanostructured lipid carriers: promising drug delivery systems for future clinics. Nanomedicine. 2016, 12:143-61. 10.1016\/j.nano.2015.09.004","journal-title":"Nanomedicine"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.102171","article-title":"Muco-adhesive clarithromycin-loaded nanostructured lipid carriers for ocular delivery: formulation, characterization, cytotoxicity and stability","volume":"61","author":"Makoni PA","year":"2020","unstructured":"Makoni PA, Khamanga SM, Walker RB. Muco-adhesive clarithromycin-loaded nanostructured lipid carriers for ocular delivery: formulation, characterization, cytotoxicity and stability. J Drug Deliv Sci Technol. 2020, 61:102171. 10.1016\/j.jddst.2020.102171","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2013.08.013","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art","volume":"86","author":"Weber S","year":"2014","unstructured":"Weber S, Zimmer A, Pardeike J. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art. Eur J Pharm Biopharm. 2014, 86:7-22. 10.1016\/j.ejpb.2013.08.013","journal-title":"Eur J Pharm Biopharm"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2017-0248","article-title":"Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment","volume":"12","author":"Vieira AC","year":"2017","unstructured":"Vieira AC, Magalh\u00e3es J, Rocha S, et al.. Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment. Nanomedicine (Lond). 2017, 12:2721-36. 10.2217\/nnm-2017-0248","journal-title":"Nanomedicine (Lond)"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.05.070","article-title":"Nanostructured lipid carriers-based drug delivery for treating various lung diseases: a state-of-the-art review","volume":"547","author":"Patil TS","year":"2018","unstructured":"Patil TS, Deshpande AS. Nanostructured lipid carriers-based drug delivery for treating various lung diseases: a state-of-the-art review. Int J Pharm. 2018, 547:209-25. 10.1016\/j.ijpharm.2018.05.070","journal-title":"Int J Pharm"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-014-1572-3","article-title":"Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery","volume":"32","author":"Song X","year":"2015","unstructured":"Song X, Lin Q, Guo L, et al.. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery. Pharm Res. 2015, 32:1741-51. 10.1007\/s11095-014-1572-3","journal-title":"Pharm Res"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S104395","article-title":"Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis","volume":"10","author":"Pinheiro M","year":"2016","unstructured":"Pinheiro M, Ribeiro R, Vieira A, Andrade F, Reis S. Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis. Drug Des Devel Ther. 2016, 10:2467-75. 10.2147\/DDDT.S104395","journal-title":"Drug Des Devel Ther"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2018.12.003","article-title":"Functionalized rifampicin-loaded nanostructured lipid carriers enhance macrophages uptake and antimycobacterial activity","volume":"175","author":"Carneiro SP","year":"2019","unstructured":"Carneiro SP, Carvalho KV, de Oliveira Aguiar Soares RD, Carneiro CM, de Andrade MH, Duarte RS, Dos Santos OD. Functionalized rifampicin-loaded nanostructured lipid carriers enhance macrophages uptake and antimycobacterial activity. Colloids Surf B Biointerfaces. 2019, 175:306-13. 10.1016\/j.colsurfb.2018.12.003","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122041","article-title":"Application of lipid-based nanocarriers for antitubercular drug delivery: a review","volume":"13","author":"Buya AB","year":"2021","unstructured":"Buya AB, Witika BA, Bapolisi AM, et al.. Application of lipid-based nanocarriers for antitubercular drug delivery: a review. Pharmaceutics. 2021, 13:2041. 10.3390\/pharmaceutics13122041","journal-title":"Pharmaceutics"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2019.06.036","article-title":"Experimental validation of biocompatible nanostructured lipid carriers of sophorolipid: optimization, characterization and in-vitro evaluation","volume":"181","author":"Kanwar R","year":"2019","unstructured":"Kanwar R, Gradzielski M, Prevost S, Appavou MS, Mehta SK. Experimental validation of biocompatible nanostructured lipid carriers of sophorolipid: optimization, characterization and in-vitro evaluation. Colloids Surf B Biointerfaces. 2019, 181:845-55. 10.1016\/j.colsurfb.2019.06.036","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2018.1431648","article-title":"Comparative study of oral lipid nanoparticle formulations (LNFs) for chemical stabilization of antitubercular drugs: physicochemical and cellular evaluation","volume":"46","author":"Banerjee S","year":"2018","unstructured":"Banerjee S, Roy S, Nath Bhaumik K, Kshetrapal P, Pillai J. Comparative study of oral lipid nanoparticle formulations (LNFs) for chemical stabilization of antitubercular drugs: physicochemical and cellular evaluation. Artif Cells Nanomed Biotechnol. 2018, 46:540-58. 10.1080\/21691401.2018.1431648","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.3390\/molecules201219822","article-title":"A nanostructured lipid system as a strategy to improve the in vitro antibacterial activity of copper(II) complexes","volume":"20","author":"da Silva PB","year":"2015","unstructured":"da Silva PB, Bonif\u00e1cio BV, Frem RC, et al.. A nanostructured lipid system as a strategy to improve the in vitro antibacterial activity of copper(II) complexes. Molecules. 2015, 20:22534-45. 10.3390\/molecules201219822","journal-title":"Molecules"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S127048","article-title":"Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against Mycobacterium tuberculosis","volume":"11","author":"Sato MR","year":"2017","unstructured":"Sato MR, Oshiro Junior JA, Machado RT, et al.. Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against Mycobacterium tuberculosis. Drug Des Devel Ther. 2017, 11:909-21. 10.2147\/DDDT.S127048","journal-title":"Drug Des Devel Ther"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1691\/ph.2019.9110","article-title":"Copper(II) complex-loaded castor oil-based nanostructured lipid carriers used against Mycobacterium tuberculosis : development, characterisation, in vitro and in vivo biological assays","volume":"74","author":"Sato MR","year":"2019","unstructured":"Sato MR, Oshiro-Junior JA, Souza PC, et al.. Copper(II) complex-loaded castor oil-based nanostructured lipid carriers used against Mycobacterium tuberculosis : development, characterisation, in vitro and in vivo biological assays. Pharmazie. 2019, 74:715-20. 10.1691\/ph.2019.9110","journal-title":"Pharmazie"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.05.005","article-title":"Microemulsion utility in pharmaceuticals: implications for multi-drug delivery","volume":"526","author":"Callender SP","year":"2017","unstructured":"Callender SP, Mathews JA, Kobernyk K, Wettig SD. Microemulsion utility in pharmaceuticals: implications for multi-drug delivery. Int J Pharm. 2017, 526:425-42. 10.1016\/j.ijpharm.2017.05.005","journal-title":"Int J Pharm"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.03.008","article-title":"Nanoemulsion: concepts, development and applications in drug delivery","volume":"252","author":"Singh Y","year":"2017","unstructured":"Singh Y, Meher JG, Raval K, Khan FA, Chaurasia M, Jain NK, Chourasia MK. Nanoemulsion: concepts, development and applications in drug delivery. J Control Release. 2017, 252:28-49. 10.1016\/j.jconrel.2017.03.008","journal-title":"J Control Release"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2016.1218462","article-title":"From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)","volume":"14","author":"Rehman FU","year":"2017","unstructured":"Rehman FU, Shah KU, Shah SU, Khan IU, Khan GM, Khan A. From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS). Expert Opin Drug Deliv. 2017, 14:1325-40. 10.1080\/17425247.2016.1218462","journal-title":"Expert Opin Drug Deliv"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2003.10.026","article-title":"Nanoemulsions: a new vehicle for skincare products","volume":"108-109","author":"Sonneville-Aubrun O","year":"2004","unstructured":"Sonneville-Aubrun O, Simonnet JT, L'Alloret F. Nanoemulsions: a new vehicle for skincare products. Adv Colloid Interface Sci. 2004, 108-109:145-9. 10.1016\/j.cis.2003.10.026","journal-title":"Adv Colloid Interface Sci"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-010-0309-1","article-title":"Nano-emulsions and micro-emulsions: clarifications of the critical differences","volume":"28","author":"Anton N","year":"2011","unstructured":"Anton N, Vandamme TF. Nano-emulsions and micro-emulsions: clarifications of the critical differences. Pharm Res. 2011, 28:978-85. 10.1007\/s11095-010-0309-1","journal-title":"Pharm Res"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.3390\/ph15091064","article-title":"Self-emulsifying drug delivery systems (SEDDS): measuring energy dynamics to determine thermodynamic and kinetic stability","volume":"15","author":"Rehman FU","year":"2022","unstructured":"Rehman FU, Farid A, Shah SU, et al.. Self-emulsifying drug delivery systems (SEDDS): measuring energy dynamics to determine thermodynamic and kinetic stability. Pharmaceuticals (Basel). 2022, 15:1064. 10.3390\/ph15091064","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/j.cocis.2008.01.005","article-title":"Nano-emulsions: new applications and optimization of their preparation","volume":"13","author":"Gutierrez JM","year":"2008","unstructured":"Gutierrez JM, Gonzalez C, Maestro A, Sole I, Pey CM, Nolla J. Nano-emulsions: new applications and optimization of their preparation. Curr Opin Colloid Interface Sci. 2008, 13:245-51. 10.1016\/j.cocis.2008.01.005","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2009.05.014","article-title":"The universality of low-energy nano-emulsification","volume":"377","author":"Anton N","year":"2009","unstructured":"Anton N, Vandamme TF. The universality of low-energy nano-emulsification. Int J Pharm. 2009, 377:142-7. 10.1016\/j.ijpharm.2009.05.014","journal-title":"Int J Pharm"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2003.10.023","article-title":"Formation and stability of nano-emulsions","volume":"108-109","author":"Tadros T","year":"2004","unstructured":"Tadros T, Izquierdo P, Esquena J, Solans C. Formation and stability of nano-emulsions. Adv Colloid Interface Sci. 2004, 108-109:303-18. 10.1016\/j.cis.2003.10.023","journal-title":"Adv Colloid Interface Sci"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2004.00914.x","article-title":"New vehicle based on a microemulsion for topical ocular administration of dexamethasone","volume":"32","author":"Fialho SL","year":"2004","unstructured":"Fialho SL, da Silva-Cunha A. New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin Exp Ophthalmol. 2004, 32:626-32. 10.1111\/j.1442-9071.2004.00914.x","journal-title":"Clin Exp Ophthalmol"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.11.049","article-title":"Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications","volume":"270","author":"Rai VK","year":"2018","unstructured":"Rai VK, Mishra N, Yadav KS, Yadav NP. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications. J Control Release. 2018, 270:203-25. 10.1016\/j.jconrel.2017.11.049","journal-title":"J Control Release"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2020.104753","article-title":"RP-HPLC method for quantitative estimation of efinaconazole in topical microemulsion and microemulsion-based-gel formulations and in presence of its degradation products","volume":"155","author":"Agrawal V","year":"2020","unstructured":"Agrawal V, Patel R, Patel M, Thanki K, Mishra S. RP-HPLC method for quantitative estimation of efinaconazole in topical microemulsion and microemulsion-based-gel formulations and in presence of its degradation products. Microchem J. 2020, 155:104753. 10.1016\/j.microc.2020.104753","journal-title":"Microchem J"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2018.10.014","article-title":"Successful development of oral SEDDS: screening of excipients from the industrial point of view","volume":"142","author":"Nardin I","year":"2019","unstructured":"Nardin I, K\u00f6llner S. Successful development of oral SEDDS: screening of excipients from the industrial point of view. Adv Drug Deliv Rev. 2019, 142:128-40. 10.1016\/j.addr.2018.10.014","journal-title":"Adv Drug Deliv Rev"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2007.06.012","article-title":"Analysis of Tween based microemulsion in the presence of TB drug rifampicin","volume":"60","author":"Mehta SK","year":"2007","unstructured":"Mehta SK, Kaur G, Bhasin KK. Analysis of Tween based microemulsion in the presence of TB drug rifampicin. Colloids Surf B Biointerfaces. 2007, 60:95-104. 10.1016\/j.colsurfb.2007.06.012","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.58.1332","article-title":"Formulation and physicochemical characterization of Imwitor 308 based self microemulsifying drug delivery systems","volume":"58","author":"Zargar-Shoshtari S","year":"2010","unstructured":"Zargar-Shoshtari S, Wen J, Alany RG. Formulation and physicochemical characterization of Imwitor 308 based self microemulsifying drug delivery systems. Chem Pharm Bull (Tokyo). 2010, 58:1332-8. 10.1248\/cpb.58.1332","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23857","article-title":"Probing location of anti-TB drugs loaded in Brij 96 microemulsions using thermoanalytical and photophysical approach","volume":"103","author":"Kaur G","year":"2014","unstructured":"Kaur G, Mehta SK. Probing location of anti-TB drugs loaded in Brij 96 microemulsions using thermoanalytical and photophysical approach. J Pharm Sci. 2014, 103:937-44. 10.1002\/jps.23857","journal-title":"J Pharm Sci"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24469","article-title":"Coencapsulation of hydrophobic and hydrophilic antituberculosis drugs in synergistic Brij 96 microemulsions: a biophysical characterization","volume":"104","author":"Kaur G","year":"2015","unstructured":"Kaur G, Mehta SK, Kumar S, Bhanjana G, Dilbaghi N. Coencapsulation of hydrophobic and hydrophilic antituberculosis drugs in synergistic Brij 96 microemulsions: a biophysical characterization. J Pharm Sci. 2015, 104:2203-12. 10.1002\/jps.24469","journal-title":"J Pharm Sci"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.05.061","article-title":"Solidified SNEDDS for the oral delivery of rifampicin: evaluation, proof of concept, in vivo kinetics, and in silico GastroPlusTM simulation","volume":"566","author":"Hussain A","year":"2019","unstructured":"Hussain A, Shakeel F, Singh SK, Alsarra IA, Faruk A, Alanazi FK, Peter Christoper GV. Solidified SNEDDS for the oral delivery of rifampicin: evaluation, proof of concept, in vivo kinetics, and in silico GastroPlusTM simulation. Int J Pharm. 2019, 566:203-17. 10.1016\/j.ijpharm.2019.05.061","journal-title":"Int J Pharm"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1080\/713840401","article-title":"Incorporation of antibiotics in liposomes designed for tuberculosis therapy by inhalation","volume":"10","author":"Justo OR","year":"2003","unstructured":"Justo OR, Moraes AM. Incorporation of antibiotics in liposomes designed for tuberculosis therapy by inhalation. Drug Deliv. 2003, 10:201-7. 10.1080\/713840401","journal-title":"Drug Deliv"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics4040590","article-title":"Composition influence on pulmonary delivery of rifampicin liposomes","volume":"4","author":"Manca ML","year":"2012","unstructured":"Manca ML, Sinico C, Maccioni AM, Diez O, Fadda AM, Manconi M. Composition influence on pulmonary delivery of rifampicin liposomes. Pharmaceutics. 2012, 4:590-606. 10.3390\/pharmaceutics4040590","journal-title":"Pharmaceutics"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.4103\/0971-6580.155361","article-title":"Rifapentine-proliposomes for inhalation: in vitro and in vivo toxicity","volume":"21","author":"Patil-Gadhe AA","year":"2014","unstructured":"Patil-Gadhe AA, Kyadarkunte AY, Pereira M, Jejurikar G, Patole MS, Risbud A, Pokharkar VB. Rifapentine-proliposomes for inhalation: in vitro and in vivo toxicity. Toxicol Int. 2014, 21:275-82. 10.4103\/0971-6580.155361","journal-title":"Toxicol Int"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1002\/slct.201902039","article-title":"Antimicrobial effects of ZnPc delivered into liposomes on multidrug resistant (MDR)-Mycobacterium tuberculosis","volume":"4","author":"Miretti M","year":"2019","unstructured":"Miretti M, Juri L, Cosiansi MC, Tempesti TC, Baumgartner MT. Antimicrobial effects of ZnPc delivered into liposomes on multidrug resistant (MDR)-Mycobacterium tuberculosis. ChemistrySelect. 2019, 4:9726-30. 10.1002\/slct.201902039","journal-title":"ChemistrySelect"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1334-y","article-title":"Ethambutol-loaded solid lipid nanoparticles as dry powder inhalable formulation for tuberculosis therapy","volume":"20","author":"Nemati E","year":"2019","unstructured":"Nemati E, Mokhtarzadeh A, Panahi-Azar V, et al.. Ethambutol-loaded solid lipid nanoparticles as dry powder inhalable formulation for tuberculosis therapy. AAPS PharmSciTech. 2019, 20:120. 10.1208\/s12249-019-1334-y","journal-title":"AAPS PharmSciTech"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1080\/1061186X.2019.1613409","article-title":"Mechanisms of the effectiveness of lipid nanoparticle formulations loaded with anti-tubercular drugs combinations toward overcoming drug bioavailability in\u00a0tuberculosis","volume":"28","author":"Banerjee S","year":"2020","unstructured":"Banerjee S, Roy S, Bhaumik KN, Pillai J. Mechanisms of the effectiveness of lipid nanoparticle formulations loaded with anti-tubercular drugs combinations toward overcoming drug bioavailability in\u00a0tuberculosis. J Drug Target. 2020, 28:55-69. 10.1080\/1061186X.2019.1613409","journal-title":"J Drug Target"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2016.05.035","article-title":"Six months versus nine months anti-tuberculous therapy for female genital tuberculosis: a randomized controlled trial","volume":"203","author":"Sharma JB","year":"2016","unstructured":"Sharma JB, Singh N, Dharmendra S, et al.. Six months versus nine months anti-tuberculous therapy for female genital tuberculosis: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2016, 203:264-73. 10.1016\/j.ejogrb.2016.05.035","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2011.10.034","article-title":"The effect of tuberculosis on ovarian reserve among women undergoing IVF in India","volume":"117","author":"Malhotra N","year":"2012","unstructured":"Malhotra N, Sharma V, Bahadur A, Sharma JB, Roy KK, Kumar S. The effect of tuberculosis on ovarian reserve among women undergoing IVF in India. Int J Gynaecol Obstet. 2012, 117:40-4. 10.1016\/j.ijgo.2011.10.034","journal-title":"Int J Gynaecol Obstet"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2010.12.014","article-title":"Genital tuberculosis among infertile women and fertility outcome after antitubercular therapy","volume":"113","author":"Kulshrestha V","year":"2011","unstructured":"Kulshrestha V, Kriplani A, Agarwal N, Singh UB, Rana T. Genital tuberculosis among infertile women and fertility outcome after antitubercular therapy. Int J Gynaecol Obstet. 2011, 113:229-34. 10.1016\/j.ijgo.2010.12.014","journal-title":"Int J Gynaecol Obstet"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijtb.2019.06.003","article-title":"Sharma's sigmoid colonic adhesive band - a new laparoscopic sign in female genital tuberculosis","volume":"67","author":"Sharma JB","year":"2020","unstructured":"Sharma JB. Sharma's sigmoid colonic adhesive band - a new laparoscopic sign in female genital tuberculosis. Indian J Tuberc. 2020, 67:327-32. 10.1016\/j.ijtb.2019.06.003","journal-title":"Indian J Tuberc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/317660-current-advances-in-lipid-based-drug-delivery-systems-as-nanocarriers-for-the-management-of-female-genital-tuberculosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T05:01:51Z","timestamp":1732597311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/317660-current-advances-in-lipid-based-drug-delivery-systems-as-nanocarriers-for-the-management-of-female-genital-tuberculosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":119,"URL":"https:\/\/doi.org\/10.7759\/cureus.74452","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,25]]}}}